TABLE 5.

Summary of potential therapeutic drugs for COVID-19.

Intervention	Type	Mechanisms	References
Remdesivir	Antiviral	Remdesivir interferes with virus RNA polymerases to inhibit virus	[120, 129]
Lopinavir/ritonavir	Antiviral	Inhibits 3CL protease activity, blockage of protein processing	[123]
Favipiravir	Antiviral	Inhibits viral RNA polymerase, thus interfering with viral replication	[137]
Hydroxychloroquine/Chloroquine	Antiviral/Antimalaria	Endosomal acidification fusion inhibitor anti-inflammatory activity	[129]
Convalescent plasma	Antiviral	Convalescent plasma from cured patients provides a protective antibody against SARS-CoV-2	[144]
Tocilizumab	mAb	Interleukin-6 inhibitor, humanized mAb targeting IL-6, immunosuppressive, blockage of a cytokine storm	[151, 152]
Bevacizumab	mAb	Humanized mAb targeting VEGF	[154]